Vogt-Koyanagi-Harada Disease
Ocul Immunol Inflamm. 2024 May;32(4):363-366. doi: 10.1080/09273948.2024.2331401. Epub 2024 Apr 24.NO ABSTRACTPMID:38657222 | DOI:10.1080/09273948.2024.2331401 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 24, 2024 Category: Allergy & Immunology Authors: Ilknur Tugal-Tutkun Derrick P Smit Ahmed M Abu El-Asrar Carl P Herbort Jennifer E Thorne Source Type: research
Uveitis-Glaucoma-Hyphema Syndrome Secondary to Implantable Collamer Lens
Conclusion: We present the first published case worldwide about UGH syndrome secondary to ICL. This is an unusual complication, and measures can be taken to avoid it. This provides evidence of the importance of postoperative follow-up by the surgeon and appropriate work-up when such cases are suspected.PMID:38652606 | DOI:10.1080/09273948.2024.2342386 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: Khaled G Almasri Francesco Pichi Source Type: research
Work Productivity and Activities of Daily Living in Working Patients with Uveitis
CONCLUSIONS: Active uveitis and ocular comorbidities are significantly associated with increased overall work impairment and impairment in activities of daily living in working patients with uveitis.PMID:38652637 | DOI:10.1080/09273948.2024.2343071 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: Juan Luis S ánchez Sevila Jos é Rosas Gómez de Salazar Mar Segu í Crespo Source Type: research
Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study
CONCLUSIONS: In PNIU children who reached remission for 6 months, ADA dose reduction and withdrawal were associated with a high risk of inflammation recurrence. Timely adjustment of ADA to the last effective dosage frequency can regain control of the inflammation. Detection of ADA serum levels in patients with recurrence may help find the appropriate interval of ADA use.PMID:38652891 | DOI:10.1080/09273948.2024.2343084 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: P D Yuan Y W Hu X Q Chen G Y Chen Y Pan H Y Lao D Liang Source Type: research
Uveitis-Glaucoma-Hyphema Syndrome Secondary to Implantable Collamer Lens
Conclusion: We present the first published case worldwide about UGH syndrome secondary to ICL. This is an unusual complication, and measures can be taken to avoid it. This provides evidence of the importance of postoperative follow-up by the surgeon and appropriate work-up when such cases are suspected.PMID:38652606 | DOI:10.1080/09273948.2024.2342386 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: Khaled G Almasri Francesco Pichi Source Type: research
Work Productivity and Activities of Daily Living in Working Patients with Uveitis
CONCLUSIONS: Active uveitis and ocular comorbidities are significantly associated with increased overall work impairment and impairment in activities of daily living in working patients with uveitis.PMID:38652637 | DOI:10.1080/09273948.2024.2343071 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: Juan Luis S ánchez Sevila Jos é Rosas Gómez de Salazar Mar Segu í Crespo Source Type: research
Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study
CONCLUSIONS: In PNIU children who reached remission for 6 months, ADA dose reduction and withdrawal were associated with a high risk of inflammation recurrence. Timely adjustment of ADA to the last effective dosage frequency can regain control of the inflammation. Detection of ADA serum levels in patients with recurrence may help find the appropriate interval of ADA use.PMID:38652891 | DOI:10.1080/09273948.2024.2343084 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 23, 2024 Category: Allergy & Immunology Authors: P D Yuan Y W Hu X Q Chen G Y Chen Y Pan H Y Lao D Liang Source Type: research
Ophthalmological and Neurological Findings in Patients with Idiopathic Uveitis Associated with Retinal Vasculitis and the Relation with the HLA DR15 Allele
CONCLUSION: Although the majority of tested patients was carrying at least one HLA DRB1-15 allele, there was no difference in ophthalmological and neurological findings in both groups.PMID:38648262 | DOI:10.1080/09273948.2024.2316759 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 22, 2024 Category: Allergy & Immunology Authors: Vincent De Man Sophie Bataillie Catherine Cassiman Lise Sels Pieter-Paul Schauwvlieghe Source Type: research
Coinfection of Ocular Toxoplasmosis and Ocular Toxocariasis in the Same Patient
CONCLUSION: Coinfections of zoonoses are related to socioeconomic environment and individual characteristics of the host. Ocular toxoplasmosis and ocular toxocariasis may present with different scenarios. To our knowledge, this is the first case of a coinfection of ocular toxoplasmosis and ocular toxocariasis in the same patient. A thorough ophthalmological examination and detailed anamnesis are important for diagnosis.PMID:38648624 | DOI:10.1080/09273948.2024.2344038 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 22, 2024 Category: Allergy & Immunology Authors: Deniz Yalcinbayir Seyda Yalcinbayir Ozgur Yalcinbayir Source Type: research
Anterior Vitreous Objective Assessment in Uveitis: An Anterior Segment Swept Source Optical Coherence Tomography Study
CONCLUSIONS: We were able to visualize and objectively evaluate changes occurring in the AV in eyes with uveitis by means of a commercially available SS-ASOCT. OCT-cells in the AV could represent an adjunctive tool in the objective evaluation of intraocular inflammation.PMID:38648627 | DOI:10.1080/09273948.2024.2339435 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 22, 2024 Category: Allergy & Immunology Authors: Alessandro Invernizzi Chiara Zaffalon Priscilla Manni Federico Zicarelli Domenico Chisari Chantal Adani Valentina Mastrofilippo Elena Bolletta Fabrizio Gozzi Luca De Simone Giovanni Staurenghi Luca Cimino Source Type: research
Herpes Zoster Chorioretinopathy: A Case Series
CONCLUSIONS: Our series suggests that herpetic chorioretinopathy may be a relatively benign process that presents late and may involve large areas of the posterior choroid.PMID:38639557 | DOI:10.1080/09273948.2024.2338271 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 19, 2024 Category: Allergy & Immunology Authors: Ashley Li Matias Soifer Anthony R Cox Matthew Debiec Tejaswini Matsyaraja Sangeeta Khanna Shilpa Kodati Source Type: research
Value of Serum Asymmetric Dimethylarginine (ADMA) As a Novel Biomarker for Uveitis in Beh çet's Disease
CONCLUSION: Serum ADMA level can serve as a novel biomarker of uveitis in BD and its severity with good diagnostic accuracy, regardless of its site or activity.PMID:38626414 | DOI:10.1080/09273948.2024.2342378 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 16, 2024 Category: Allergy & Immunology Authors: Omima Ahmed Sayed Rasha Ali Abdel-Magied Mostafa Ahmed Abu Elela Abdallah Mm Safwat Ahmed M Abdel-Nasser Source Type: research
CMV-Related Anterior Uveitis in a Mediterranean European Population: Clinical Features, Prognosis, and Long-Term Treatment Outcomes
CONCLUSION: In this immunocompetent southern European population, four distinct clinical presentation patterns were further confirmed, and possible biomarkers such as PS, KPs, and endotheliitis were newly reported to influence treatment outcomes. Large-scale studies could provide a more effective customized treatment protocol.PMID:38621024 | DOI:10.1080/09273948.2024.2329315 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 15, 2024 Category: Allergy & Immunology Authors: Paris Tranos Nikos Markomichelakis Spyridon Koronis Georgios Sidiropoulos Marianna Tranou Achilleas Rasoglou Panagiotis Stavrakas Source Type: research
